30619378 31660419 31140323 33393506 32871587 29195742 31968213 30650380 30352429 33995418 34759919 33255895 31102718 31780366 33837614 29490164 34046041 34199563 31703913 35327450 35521736 35053338 34631930 29296912 34084173 31839483 29616042 3413589 - Search Results

Year	Number of Results
2017	4
2018	9
2019	15
2020	10
2021	17
2022	7

1

Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.

Fu C, Jiang A. Fu C, et al. Front Immunol. 2018 Dec 20;9:3059. doi: 10.3389/fimmu.2018.03059. eCollection 2018. Front Immunol. 2018. PMID: 30619378 Free PMC article. Review.

2

Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer.

Pipe S, Leebeek FWG, Ferreira V, Sawyer EK, Pasi J. Pipe S, et al. Mol Ther Methods Clin Dev. 2019 Sep 10;15:170-178. doi: 10.1016/j.omtm.2019.08.015. eCollection 2019 Dec 13. Mol Ther Methods Clin Dev. 2019. PMID: 31660419 Free PMC article. Review.

3

TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer.

Butterfield JSS, Biswas M, Shirley JL, Kumar SRP, Sherman A, Terhorst C, Ling C, Herzog RW. Butterfield JSS, et al. Hum Gene Ther Methods. 2019 Jun;30(3):81-92. doi: 10.1089/hgtb.2019.013. Hum Gene Ther Methods. 2019. PMID: 31140323 Free PMC article.

4

Overcoming innate immune barriers that impede AAV gene therapy vectors.

Muhuri M, Maeda Y, Ma H, Ram S, Fitzgerald KA, Tai PW, Gao G. Muhuri M, et al. J Clin Invest. 2021 Jan 4;131(1):e143780. doi: 10.1172/JCI143780. J Clin Invest. 2021. PMID: 33393506 Free PMC article. Review.

5

Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.

Xiao W, Chan A, Waarts MR, Mishra T, Liu Y, Cai SF, Yao J, Gao Q, Bowman RL, Koche RP, Csete IS, DelGaudio NL, Derkach A, Baik J, Yanis S, Famulare CA, Patel M, Arcila ME, Stahl M, Rampal RK, Tallman MS, Zhang Y, Dogan A, Goldberg AD, Roshal M, Levine RL. Xiao W, et al. Blood. 2021 Mar 11;137(10):1377-1391. doi: 10.1182/blood.2020007897. Blood. 2021. PMID: 32871587 Free PMC article.

6

Preclinical models to assess the immunogenicity of AAV vectors.

Ertl HCJ. Ertl HCJ. Cell Immunol. 2019 Aug;342:103722. doi: 10.1016/j.cellimm.2017.11.006. Epub 2017 Nov 23. Cell Immunol. 2019. PMID: 29195742

7

Immune Responses to Viral Gene Therapy Vectors.

Shirley JL, de Jong YP, Terhorst C, Herzog RW. Shirley JL, et al. Mol Ther. 2020 Mar 4;28(3):709-722. doi: 10.1016/j.ymthe.2020.01.001. Epub 2020 Jan 10. Mol Ther. 2020. PMID: 31968213 Free PMC article. Review.

8

Plasmacytoid Dendritic Cells: Development, Regulation, and Function.

Reizis B. Reizis B. Immunity. 2019 Jan 15;50(1):37-50. doi: 10.1016/j.immuni.2018.12.027. Immunity. 2019. PMID: 30650380 Free PMC article. Review.

9

Exposure to wild-type AAV drives distinct capsid immunity profiles in humans.

Kuranda K, Jean-Alphonse P, Leborgne C, Hardet R, Collaud F, Marmier S, Costa Verdera H, Ronzitti G, Veron P, Mingozzi F. Kuranda K, et al. J Clin Invest. 2018 Dec 3;128(12):5267-5279. doi: 10.1172/JCI122372. Epub 2018 Oct 22. J Clin Invest. 2018. PMID: 30352429 Free PMC article.

10

Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction.

Muhuri M, Zhan W, Maeda Y, Li J, Lotun A, Chen J, Sylvia K, Dasgupta I, Arjomandnejad M, Nixon T, Keeler AM, Manokaran S, He R, Su Q, Tai PWL, Gao G. Muhuri M, et al. Front Immunol. 2021 Apr 28;12:674242. doi: 10.3389/fimmu.2021.674242. eCollection 2021. Front Immunol. 2021. PMID: 33995418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results